DOSSIER · 13F Holders · Q2 2026Healthcare · Biological Products, (No Diagnostic Substances)
KYMR
KYMERA THERAPEUTICS INC
294 institutions still hold KYMERA THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 501575104·Biological Products, (No Diagnostic Substances)·294 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
294 institutions reported KYMR in Q2 2026. FMR LLC leads at 17.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 15
274 more holders available. Log in →